JAOA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

JAOA • Vol 109 • No 1 • January 2009 • 20-25
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colameco, S.
Right arrow Articles by Coren, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colameco, S.
Right arrow Articles by Coren, J. S.

CLINICAL PRACTICE

Opioid-Induced Endocrinopathy

 Stephen Colameco, MD, MEd; Joshua S. Coren, DO, MBA

From the Department of Family Medicine at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine in Stratford.

Address correspondence to Joshua S. Coren, DO, MBA, 310 Creek Crossing Blvd, Hainesport, NJ 08036-2767. E-mail: corenjo{at}umdnj.edu

Debilitating chronic nonmalignant pain is often managed using opioid medications. However, with increased use of this drug class comes concern about adverse effects on patients' endocrine function. In the present review, the authors discuss opioid-induced interference with the hypothalamic-pituitary-gonadal axis, effects on adrenal androgen production, and endocrine deficiency. In addition, the authors describe symptomology for opioid-induced endocrinopathy as well as diagnostic testing options. Treatment modalities for those afflicted with this condition are also described.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Osteopathic Association.